Inari Medical


ATLANTA, GA – – (Globe Newswire – March 1, 2024) – – Holzer & Holzer, LLC is investigating whether Inari Medical, Inc. (“Inari Medical” or the “Company”) (NASDAQ: NARI) complied with federal securities laws. On February 28, 2024, Inari Medical disclosed that the Company had “received a civil investigative demand (“CID”) from the U.S. Department of Justice, Civil Division, in connection with an investigation under the federal Anti-Kickback Statute and Civil False Claims Act (the “Investigation”). The CID requests information and documents primarily relating to meals and consulting service payments provided to health care professionals (“HCPs”).” Following this news, the Company’s stock price declined.

If you purchased Inari Medical stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at  or Joshua Karr, Esq. at, call our toll-free number at (888) 508-6832, or visit our website at discuss your legal rights.

Registration Deadline

Lead Plaintiff Deadline Has Passed

Submit Your Information

Shares Purchased(Required)
Date of Shares Purchased
Number of Shares Acquired
Acquisition Price Per Share
Shares Sold
Date of Shares Sold
Number of Shares Sold
Selling Price Per Share